[go: up one dir, main page]

AU4040699A - Use of nitric oxide synthase inhibitors in the manufacture of a medicament for the prophylaxis or treatment of bacterial infection - Google Patents

Use of nitric oxide synthase inhibitors in the manufacture of a medicament for the prophylaxis or treatment of bacterial infection

Info

Publication number
AU4040699A
AU4040699A AU40406/99A AU4040699A AU4040699A AU 4040699 A AU4040699 A AU 4040699A AU 40406/99 A AU40406/99 A AU 40406/99A AU 4040699 A AU4040699 A AU 4040699A AU 4040699 A AU4040699 A AU 4040699A
Authority
AU
Australia
Prior art keywords
prophylaxis
medicament
manufacture
treatment
nitric oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40406/99A
Other languages
English (en)
Inventor
Wendy Karen Alderton
Richard Graham Knowles
Christoph Hubertus LADEL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU4040699A publication Critical patent/AU4040699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU40406/99A 1998-05-15 1999-05-12 Use of nitric oxide synthase inhibitors in the manufacture of a medicament for the prophylaxis or treatment of bacterial infection Abandoned AU4040699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9810299 1998-05-15
GBGB9810299.9A GB9810299D0 (en) 1998-05-15 1998-05-15 Use of nitric oxide synthase inhibitors
PCT/EP1999/003265 WO1999059566A1 (en) 1998-05-15 1999-05-12 Use of nitric oxide synthase inhibitors in the manufacture of a medicament for the prophylaxis or treatment of bacterial infection

Publications (1)

Publication Number Publication Date
AU4040699A true AU4040699A (en) 1999-12-06

Family

ID=10832007

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40406/99A Abandoned AU4040699A (en) 1998-05-15 1999-05-12 Use of nitric oxide synthase inhibitors in the manufacture of a medicament for the prophylaxis or treatment of bacterial infection

Country Status (6)

Country Link
AR (1) AR020587A1 (es)
AU (1) AU4040699A (es)
GB (1) GB9810299D0 (es)
MA (1) MA24854A1 (es)
PE (1) PE20000474A1 (es)
WO (1) WO1999059566A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0031179D0 (en) * 2000-12-21 2001-01-31 Glaxo Group Ltd Nitric oxide synthase inhibitors
WO2003097050A2 (en) * 2002-05-16 2003-11-27 Pharmacia Corporation A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US7838532B2 (en) 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
CN102202649A (zh) 2008-10-07 2011-09-28 Mpex医药有限公司 用于改进的药物动力学的氟喹诺酮气雾剂制剂
PL2346509T3 (pl) 2008-10-07 2021-03-08 Horizon Orphan Llc Lewofloksacyna w postaci aerozolu dla zmniejszania stanu zapalnego płuc
KR20120100904A (ko) 2009-09-04 2012-09-12 엠펙스 파마슈티컬즈, 인코포레이티드 낭포성 섬유증을 치료하기 위한 에어로졸화된 레보플록사신의 용도
DE102010055322A1 (de) * 2010-12-21 2012-06-21 Christian-Albrechts-Universität Zu Kiel Antibakteriell und antimykotisch wirkende Substanzen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312835A (en) * 1989-09-13 1994-05-17 Board Of Regents, The University Of Texas System Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension
US5545625A (en) * 1994-12-12 1996-08-13 The Medical College Of Wisconsin Research Foundation, Inc. Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction
GB9425701D0 (en) * 1994-12-20 1995-02-22 Wellcome Found Enzyme inhibitors
MY117948A (en) * 1997-01-13 2004-08-30 Glaxo Group Ltd Nitride oxide synthase inhibitors.
GB9702312D0 (en) * 1997-02-05 1997-03-26 Univ London Method for identifying selective inhibitors of nitric oxide synthase

Also Published As

Publication number Publication date
MA24854A1 (fr) 1999-12-31
GB9810299D0 (en) 1998-07-15
AR020587A1 (es) 2002-05-22
WO1999059566A1 (en) 1999-11-25
PE20000474A1 (es) 2000-06-06

Similar Documents

Publication Publication Date Title
AU2001253265A1 (en) Oral treatment systems
IL168279A (en) Use of liposomal and aminoglycoside composition to prepare a drug for the treatment or improvement of infection
EP1576963A3 (en) Use of botulinum toxin in the treatment of pain due to an infection
AU2002232550A1 (en) Device and method for treatment of surface infections with nitric oxide
HK1049656A1 (zh) Fab i抑制剂
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
AU2002243023A1 (en) Compositions for preventing and/or treating oral diseases
IL146255A0 (en) Attenuated microorganisms for the treatment of infection
ZA200108215B (en) Compositions and methods for treatment of staphylococcal infection.
AU2002356868A1 (en) Methods for the prevention or treatment of bacterial and fungal infections
AU1602700A (en) Process for nitrous oxide purification
AU1209995A (en) Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
AU4040699A (en) Use of nitric oxide synthase inhibitors in the manufacture of a medicament for the prophylaxis or treatment of bacterial infection
AU2001259507A1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
GB9922752D0 (en) Medical devices and treatment and prophylaxis
AU2002341207A1 (en) Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing
EP1225913B8 (en) Use of nitric oxide for the treatment of airway constriction
AU3071799A (en) Use of pkc inhibitors for the manufacture of a medicament for the treatment of cytomegalovirus infection
AU2001267177A1 (en) Diagnosis and treatment of herpes infections
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection
AU2001282277A1 (en) Treatment of mycobacterial infection
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU2001277612A1 (en) Adhesive dressings for the treatment and prophylaxis of scars
AU2001292500A1 (en) 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain
AUPR626201A0 (en) A composition for use in prophylaxis and/or treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase